These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 17655682)

  • 1. A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis.
    Lottmann H; Froeling F; Alloussi S; El-Radhi AS; Rittig S; Riis A; Persson BE
    Int J Clin Pract; 2007 Sep; 61(9):1454-60. PubMed ID: 17655682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of two sublingual types of desmopressin in 6-year-old and more children with primary nocturnal enuresis. About an international randomized cross-over study].
    Lottmann H
    Prog Urol; 2009 Feb; 19(2):132-8. PubMed ID: 19168019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis.
    Juul KV; Van Herzeele C; De Bruyne P; Goble S; Walle JV; Nørgaard JP
    Eur J Pediatr; 2013 Sep; 172(9):1235-42. PubMed ID: 23677249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
    Robson WL; Leung AK; Norgaard JP
    J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term desmopressin response in primary nocturnal enuresis: open-label, multinational study.
    Lottmann H; Baydala L; Eggert P; Klein BM; Evans J; Norgaard JP
    Int J Clin Pract; 2009 Jan; 63(1):35-45. PubMed ID: 19125991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis.
    Schulman SL; Stokes A; Salzman PM
    J Urol; 2001 Dec; 166(6):2427-31. PubMed ID: 11696804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis.
    Vande Walle JG; Bogaert GA; Mattsson S; Schurmans T; Hoebeke P; Deboe V; Norgaard JP;
    BJU Int; 2006 Mar; 97(3):603-9. PubMed ID: 16469035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focus on desmopressin and enuresis: a review of literature.
    Ferrara P; Vena F; Basile MC; Ianniello F; Gatto A
    Minerva Urol Nefrol; 2016 Feb; 68(1):14-9. PubMed ID: 24990391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
    Van de Walle J; Van Herzeele C; Raes A
    Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents.
    Stenberg A; Läckgren G
    Pediatrics; 1994 Dec; 94(6 Pt 1):841-6. PubMed ID: 7970999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral lyophylizate formulation of desmopressin: superior pharmacodynamics compared to tablet due to low food interaction.
    De Guchtenaere A; Van Herzeele C; Raes A; Dehoorne J; Hoebeke P; Van Laecke E; Vande Walle J
    J Urol; 2011 Jun; 185(6):2308-13. PubMed ID: 21511277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis.
    Michelet R; Dossche L; Van Herzeele C; Van Bocxlaer J; Vermeulen A; Vande Walle J;
    Eur J Clin Pharmacol; 2018 Mar; 74(3):297-305. PubMed ID: 29198064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray.
    De Guchtenaere A; Raes A; Vande Walle C; Hoebeke P; Van Laecke E; Donckerwolcke R; Vande Walle J
    J Urol; 2009 Jan; 181(1):302-9; discussion 309. PubMed ID: 19013601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis.
    Skoog SJ; Stokes A; Turner KL
    J Urol; 1997 Sep; 158(3 Pt 2):1035-40. PubMed ID: 9258137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults.
    Osterberg O; Savic RM; Karlsson MO; Simonsson US; Nørgaard JP; Walle JV; Agersø H
    J Clin Pharmacol; 2006 Oct; 46(10):1204-11. PubMed ID: 16988210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
    Van Herzeele C; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
    J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety profile of desmopressin tablet for enuresis in a prospective study.
    Van Herzeele C; De Bruyne P; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
    Adv Ther; 2014 Dec; 31(12):1306-16. PubMed ID: 25504157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis.
    De Bruyne P; De Guchtenaere A; Van Herzeele C; Raes A; Dehoorne J; Hoebeke P; Van Laecke E; Vande Walle J
    Eur J Pediatr; 2014 Feb; 173(2):223-8. PubMed ID: 23989967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overnight testing of renal concentrating capacity in children using desmopressin tablets: sensitivity, repeatability and non-inferiority versus intranasal spray.
    Asa Rembratt ; Jens-Kristian Jensen ; Kjell Tullus ; Staffan Mårild ;
    Scand J Urol Nephrol; 2008; 42(3):274-7. PubMed ID: 17943639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral desmopressin lyophilisate (MELT) for monosymptomatic enuresis: structured versus abrupt withdrawal.
    Ferrara P; Romano V; Cortina I; Ianniello F; Fabrizio GC; Chiaretti A
    J Pediatr Urol; 2014 Feb; 10(1):52-5. PubMed ID: 23791016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.